2023-04-26 17:10:15 ET
- CONMED press release ( NYSE: CNMD ): Q1 Non-GAAP EPS of $0.66 beats by $0.06 .
- Revenue of $295.5M (+21.9% Y/Y) beats by $28.84M .
- Now expects FY 2023 revenue between $1.205 billion and $1.250 billion, compared to its prior guidance of between $1.170 billion and $1.220 billion. The consensus revenue estimate is $1.19B.
- Now expects FY 2023 adj. EPS in the range of $3.30 to $3.50, compared to its prior range of $3.20 to $3.45. The consensus EPS estimate is $3.32.
For further details see:
CONMED Q1 results beat estimates, co raises FY 2023 guidance